Aiforia signs up to €20m in EIB venture debt
The Finnish digital-pathology company signed a milestone-based financing agreement with the European Investment Bank.
Three conditional tranches
Aiforia announced the binding agreement on July 31, 2026. The facility is divided into three tranches, beginning with €5 million; each draw depends on revenue and other milestones. A synthetic-warrant arrangement accompanies the loan.
AI for pathology
Aiforia develops software for analysing digitised tissue samples in research and clinical practice. The agreement is backed by the EU’s InvestEU programme.
Use of funds
Develop existing and new image-analysis solutions
Expand commercial operations internationally